Randomized Early Versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention - RELAx-AMI


The goal of the trial was to evaluate the effect of early abciximab administration in the emergency room (ER) or in later administration in the catheterization laboratory among patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI).